{
    "clinical_study": {
        "@rank": "124343", 
        "acronym": "OCL", 
        "arm_group": [
            {
                "arm_group_label": "CompletedExploratory A Evaluation", 
                "arm_group_type": "Experimental", 
                "description": "using OCL System"
            }, 
            {
                "arm_group_label": "Exploratory B Group", 
                "arm_group_type": "Experimental", 
                "description": "using Revel 2.0 Insulin Pump"
            }, 
            {
                "arm_group_label": "Phase 1A Group", 
                "arm_group_type": "Experimental", 
                "description": "using OCL System - procedure 1A"
            }, 
            {
                "arm_group_label": "Phase 1B Group", 
                "arm_group_type": "Experimental", 
                "description": "using OCL System - procedure 1B"
            }, 
            {
                "arm_group_label": "Phase 2 Group", 
                "arm_group_type": "Experimental", 
                "description": "using OCL System - procedure 2"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a multicenter feasibility study.  Up to 85 subjects will be enrolled in the study.\n      The goal of the study is to demonstrate that the Overnight Closed Loop (OCL) System is safe\n      to be used in an even larger study outside of hospital."
        }, 
        "brief_title": "Overnight Closed Loop Study in U.S.", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 1 Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "detailed_description": {
            "textblock": "Subjects that have met eligibility criteria will be assigned to one of the 5 different\n      groups (ie. Exploratory A Group, Exploratory B Group, Phase 1A Group, Phase 1B Group, Phase\n      2 Group). Up to 6 investigational centers will be used during this study.\n\n      There is no statistically powered study hypothesis testing.\n\n      The investigational centers will be encouraged to include subjects of different ethnicities\n      including Hispanic, Native American, and African-American.\n\n      The study is anticipated to last no more than 12 months from investigational center\n      initiation to finalization of all data entry and monitoring procedures. Subjects are\n      expected to participate for approximately 1- 2 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject is 22-75 years of age at time of screening\n\n          2. A clinical diagnosis of type 1 diabetes as determined by either medical record or\n             source documentation from qualified individual to make medical diagnosis\n\n             Exclusion Criteria that are Based on Demands of In-Clinic Study Procedures :\n\n          3. Pump therapy for greater than 6 months with use of real time CGM for any period of\n             time (ie. one day) 3 months prior to screening\n\n          4. Adequate venous access as assessed by investigator or appropriate staff\n\n          5. Subject should have an established insulin carbohydrate and insulin sensitivity\n             ratio.\n\n          6. Subject reports at the time of screening that their average fasting glucose is 60\n             mg/dL - 200 mg/dL\n\n          7. Subject reports at the time of screening that their average total daily insulin dose\n             is 15 units - 110 units.  (Insulin pump memory for this information may be used)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "22 Years"
        }, 
        "enrollment": {
            "#text": "85", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01857973", 
            "org_study_id": "CEP273"
        }, 
        "intervention": {
            "arm_group_label": [
                "CompletedExploratory A Evaluation", 
                "Exploratory B Group", 
                "Phase 1A Group", 
                "Phase 1B Group", 
                "Phase 2 Group"
            ], 
            "description": "The Overnight Closed Loop System is an investigational device intended for closed loop control of blood glucose during the night.", 
            "intervention_name": "OCL System", 
            "intervention_type": "Device", 
            "other_name": "Overnight Closed Loop System"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "OCL", 
            "Type 1 Diabetes", 
            "Sensor", 
            "Artificial calibration error"
        ], 
        "lastchanged_date": "May 19, 2014", 
        "location": [
            {
                "contact": {
                    "email": "lbedolla@amcrinstitute.com", 
                    "last_name": "Laura Bedolla", 
                    "phone": "760-466-1526"
                }, 
                "facility": {
                    "address": {
                        "city": "Escondido", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92026"
                    }, 
                    "name": "AMCR Institute, Inc. 700 West El Norte Parkway, Suite 201"
                }, 
                "investigator": {
                    "last_name": "Timothy Bailey, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Dawn.white@ucdenver.edu", 
                    "last_name": "Dawn White", 
                    "phone": "303-724-6770"
                }, 
                "facility": {
                    "address": {
                        "city": "Aurora", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80045"
                    }, 
                    "name": "Barbara Davis Center, 1775 Aurora Court, A140"
                }, 
                "investigator": {
                    "last_name": "Satish Garg, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "loria.carria@yale.edu", 
                    "last_name": "Lori Carria", 
                    "phone": "203-737-3595"
                }, 
                "facility": {
                    "address": {
                        "city": "New Haven", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06519"
                    }, 
                    "name": "Yale University School of Medicine, 2 Church Street South, Suite 404"
                }, 
                "investigator": {
                    "last_name": "Stuart Weinzimer, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "astrid.castillo@joslin.harvard.edu", 
                    "last_name": "Astrid Rogert", 
                    "phone": "617-264-2767"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Joslin Diabetes Center, One Joslin Place"
                }, 
                "investigator": {
                    "last_name": "Howard Wolpert, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "MC7M@hscmail.mcc.virginia.edu", 
                    "last_name": "Mary Oliveri", 
                    "phone": "434-982-0602"
                }, 
                "facility": {
                    "address": {
                        "city": "Charlottesville", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22903"
                    }, 
                    "name": "University of Virginia, 617 West Main Street, 4th Floor"
                }, 
                "investigator": {
                    "last_name": "Stacey Anderson, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "khughes@rainier-research.com", 
                    "last_name": "Kristin Hughes", 
                    "phone": "425-271-1720", 
                    "phone_ext": "15"
                }, 
                "facility": {
                    "address": {
                        "city": "Renton", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98057"
                    }, 
                    "name": "Rainier Clinical Research, 723 SW 10th Street, Suite 100"
                }, 
                "investigator": {
                    "last_name": "Ron Brazg, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "5", 
        "official_title": "In-Clinic Feasibility Study to Observe the Overnight Closed Loop System", 
        "overall_contact": {
            "email": "yiming.deng@medtronic.com", 
            "last_name": "Yiming Deng", 
            "phone": "818-576-5472"
        }, 
        "overall_contact_backup": {
            "email": "thomas.troub@medtronic.com", 
            "last_name": "Thomas Troub", 
            "phone": "818-576-3142"
        }, 
        "overall_official": {
            "affiliation": "Medtronic", 
            "last_name": "Scott Lee, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "clinical data obtained from this study will demonstrate system performance", 
            "measure": "No primary endpoint, only descriptive endpoints for Overnight Closed Loop (OCL) system performance", 
            "safety_issue": "Yes", 
            "time_frame": "in one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01857973"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Medtronic Diabetes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Diabetes", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}